{"id":400171,"date":"2020-12-15T11:03:12","date_gmt":"2020-12-15T16:03:12","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=400171"},"modified":"2020-12-15T11:03:12","modified_gmt":"2020-12-15T16:03:12","slug":"crohns-and-colitis-canada-awards-over-1-2-million-to-new-research-projects-through-annual-grant-competitions","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/crohns-and-colitis-canada-awards-over-1-2-million-to-new-research-projects-through-annual-grant-competitions\/","title":{"rendered":"Crohn\u2019s and Colitis Canada Awards Over $1.2 Million to New Research Projects through Annual Grant Competitions"},"content":{"rendered":"

\nLeading Canadian IBD researchers receive essential funding for projects investigating Crohn\u2019s disease and ulcerative colitis
\n<\/h2>\n
\n

TORONTO, Dec. 15, 2020 (GLOBE NEWSWIRE) — Crohn\u2019s and Colitis Canada is delighted to award over $1.2 million in new grants through its Grants-in-Aid of Research and Innovations in IBD Research grant programs. With funds distributed among five principal investigators and their teams, the grants will support novel research projects focused on Crohn\u2019s disease and ulcerative colitis, the two main forms of inflammatory bowel disease (IBD).<\/p>\n

As one of the world\u2019s largest non-governmental funders of IBD research, Crohn\u2019s and Colitis Canada has a well-known history of leading the advancement of critical research. Every funded project provides hope to the 270,000 Canadians living with the chronic autoimmune diseases \u2013 a number that researchers expect to rise to 400,000 by 2030.<\/p>\n

While Canadians of all ages live with IBD, research shows seniors are the fastest growing group and the prevalence in children has risen by more than 50% over the past 10 years. With the rising rate of IBD among Canadians and unique treatment challenges presented by all age groups, the data from the scientific community highlights the urgent need to invest in research.<\/p>\n

\u201cWe are grateful to the Crohn\u2019s and colitis community who stepped up in a difficult year to ensure we could sustain and grow our research investments. We have made great progress in gaining a better understanding of these diseases, and funding these five new projects through our grant programs ensures we don\u2019t lose momentum,\u201d says Susan Cowan, CEO of Crohn\u2019s and Colitis Canada. \u201cWith 14 Grants-in-Aid projects currently in their second or third year of funding, we\u2019re now supporting 19 grant-funded projects that address the pressing need to expand treatment options, improve patient care, and identify the mechanisms behind the diseases to allow us to discover cures. Crohn\u2019s and Colitis Canada is proud to be driving world-renowned, game-changing Crohn\u2019s and colitis research thanks to the generous support of our donors and volunteers through our annual Gutsy Walk and local fundraising activities across the country.\u201d<\/p>\n

The annual competitions for the two funding programs require principal investigators to submit research proposals that undergo a rigorous review process by a panel comprised of scientific experts, IBD nurses, and people with IBD. This year, three principal investigators and their teams are the recipients of Grants-in-Aid of Research grants, and will receive $125,000 a year for three years to advance prevention, treatments, and health policy.<\/p>\n

Crohn\u2019s and Colitis Canada is also pleased to award two Innovations in IBD Research grants to scientists and their teams. The intent of the Innovations in IBD Research program is to support scientists with new and creative ideas, which may have high risks but could result in high rewards. These one-year $50,000 grants are made possible this year thanks to funding provided by the Ross McMaster Memorial Fund.<\/p>\n

The notable researchers receiving funding through Crohn\u2019s and Colitis Canada\u2019s grants program are:<\/p>\n

Grants-in-Aid of Research Recipients:<\/p>\n